ACOG Renews Blood Clot Warnings as Bayer Increases Yaz Settlements

The Drug Risk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
YAZ LAWSUIT
Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism and believes it may be due to taking Yaz or Yasmin is urged to contact the Drug Risk Resource Center or speak with a lawyer about their legal options.

Los Angeles, CA (PRWEB) November 30, 2012

The American College of Obstetricians and Gynecologists is the latest panel to warn that birth control pills containing drospirenone such as Yaz and Yasmin may have a higher risk of causing blood clots, according to the Chicago Tribune on October 24, 2012.

The news comes as Bayer’s 3rd Quarter financial report shows the German drug maker is not only resolving thousands of Yaz and Yasmin injury claims, but is also increasing settlement amounts.

The Legal Notes and Business Development section of the Bayer Interim Financial Statement dated September 30, 2012 confirms the company has resolved almost 3,500 injury claims so far for a total cost of nearly $750 million, or an average of approximately $214,000 per case.

Bloomberg News had reported on July 31st that Bayer began settling around 1900 Yaz lawsuits at an average of around $212,000.

Bayer also confirmed in the latest report that they are only settling claims involving blood clot injuries, such as deep vein thrombosis and pulmonary embolism.

Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin is urged to contact the Drug Risk Resource Center or speak with a lawyer about their legal options.

Due to the number of patients filing claims, cases were consolidated to a special federal Multi-District Litigation court in Illinois. The formal case is known as Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois).

The news of increasing Yaz lawsuit settlement values is positive for those injured who have yet to file a claim. However, time is limited and only certain cases may qualify.

Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism and believes it may be due to taking Yaz or Yasmin is urged to contact the Drug Risk Resource Center or speak with a lawyer about their legal options.

The Drug Risk Resource Center cautions that victims should seek a lawyer with experience in defective drug litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.

For more information on the research, side effects and Yaz litigation news related to drug, or to speak with a lawyer, visit http://www.DrugRisk.com.


Contact